Topics

FDA Approves First Non-Controlled Substance Treatment for Narcolepsy

20:00 EDT 14 Aug 2019 | BioSpace

The FDA approved Wakix for the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

Original Article: FDA Approves First Non-Controlled Substance Treatment for Narcolepsy

NEXT ARTICLE

More From BioPortfolio on "FDA Approves First Non-Controlled Substance Treatment for Narcolepsy"

Quick Search

Relevant Topic

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...